WebMD and Medscape announced their 2022 Choice Awards on Nov. 10, recognizing hospitals that are preferred by patients and providers across five speciality areas: oncology, cardiology, orthopedics, neurology and gastroenterology.
Category: ROOT
6 GI partnerships in the last 30 days
From an endoscopy partnership to One GI’s expansion, here are six important gastroenterology partnerships Becker’s has reported on since Oct. 19.
$163B in surplus inventory wasted annually: Report
About 8 percent of global stock perishes or is thrown away every year, translating to about $163 billion worth of wasted inventory, Bloomberg reported Nov. 10, citing a new report from materials supplier Avery Dennison.
Test-to-treat access limited for some, study finds
Many Americans in rural areas do not have easy access to federal test-to-treat sites, according to a study published Nov. 9 in JAMA Network Open.
ChristinaCare partners with virtual care company Hims & Hers
ChristianaCare has partnered with virtual care company Hims & Hers to offer patients in several East Coast states access to in-person primary and specialty care services.
American Society of Anesthesiologists awards former president
The American Society of Anesthesiologists has honored one of its former presidents, James Grant, MD, with its annual Distinguished Service Award.
What ASC leaders need to know about the 2023 CMS final rule
CMS released its finalized 2023 Physician Fee Schedule on Nov. 1. Here are five things ASC leaders need to know.
How Cleveland Clinic uses virtual reality for neurology care
Cleveland Clinic is turning to virtual reality to improve the health of neurology patients.
Single-use endoscopy provider partners with InterMed Resources
UroViu Corp., a maker of single-use endoscopy platforms, has partnered with management organization InterMed Resources Tennessee as the exclusive distributor for all UroViu products.
FDA approves 1 COVID-19 treatment, votes against another
As some FDA-approved therapies to treat COVID-19 have been waning in efficacy against new variants, the agency approved a COVID-19-related pneumonia drug a day after it blocked authorization for another potential treatment.
